Our strategic collaborations enable us to leverage and expand our internal research and development capabilities, wisely manage our cash expenditures, and diversify risk across our pipeline.
From its inception as a technology platform company, Sunesis has partnered with large pharmaceutical companies to work on their drug discovery targets while simultaneously validating our fragment-based drug discovery platform. As Sunesis has transformed into development company, partnerships will likely continue to play an important role going forward.
Sunesis has formed strategic research and drug discovery partnerships with leading pharmaceutical and biopharmaceutical companies, including Biogen Idec Inc., Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Merck & Co. Inc. and SARcode Corporation. We continue to evaluate opportunities to form partnerships around our clinical-stage pipeline and our small molecule drug discovery capabilities.
